- Home
- KLXE vs VSTM Comparison
KLXE vs VSTM Comparison
Compare KLXE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- VSTM
- Stock Information
- Founded
- KLXE 2018
- VSTM 2010
- Country
- KLXE United States
- VSTM United States
- Employees
- KLXE N/A
- VSTM N/A
- Industry
- KLXE Oilfield Services/Equipment
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- VSTM Health Care
- Exchange
- KLXE Nasdaq
- VSTM Nasdaq
- Market Cap
- KLXE 90.4M
- VSTM 132.0M
- IPO Year
- KLXE N/A
- VSTM 2012
- Fundamental
- Price
- KLXE $4.51
- VSTM $3.88
- Analyst Decision
- KLXE Hold
- VSTM Strong Buy
- Analyst Count
- KLXE 1
- VSTM 8
- Target Price
- KLXE $4.50
- VSTM $14.57
- AVG Volume (30 Days)
- KLXE 92.5K
- VSTM 1.1M
- Earning Date
- KLXE 11-04-2024
- VSTM 11-06-2024
- Dividend Yield
- KLXE N/A
- VSTM N/A
- EPS Growth
- KLXE N/A
- VSTM N/A
- EPS
- KLXE N/A
- VSTM N/A
- Revenue
- KLXE $769,700,000.00
- VSTM $10,000,000.00
- Revenue This Year
- KLXE N/A
- VSTM N/A
- Revenue Next Year
- KLXE $3.17
- VSTM $125.69
- P/E Ratio
- KLXE N/A
- VSTM N/A
- Revenue Growth
- KLXE N/A
- VSTM N/A
- 52 Week Low
- KLXE $4.18
- VSTM $2.10
- 52 Week High
- KLXE $12.13
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- KLXE 33.44
- VSTM 63.77
- Support Level
- KLXE $4.31
- VSTM $3.11
- Resistance Level
- KLXE $4.59
- VSTM $3.76
- Average True Range (ATR)
- KLXE 0.31
- VSTM 0.33
- MACD
- KLXE -0.05
- VSTM 0.04
- Stochastic Oscillator
- KLXE 8.92
- VSTM 94.26
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.